Different roles of S100P Overexpression in Intrahepatic Cholangiocarcinoma
Shinichi Aishima(Saga University), Yoshinao Oda(Kyushu University), Ken Shirabe(Gunma University), Yohei Mano(National Center for Global Health and Medicine), Akinobu Taketomi(Hokkaido University), Yuki Tanaka(Kyushu University), Nobuhiro Fujita(Kyushu University), Yuichiro Kubo, Yoshihiko Maehara(Kyushu University)
Cited by 77
Related Papers
cHCC‐CCA
|Hepatology|2018|333
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244